And Now, a Word from the FDA | GenomeWeb

And Now, a Word from the FDA

Premium

Felix Frueh was hired by the FDA going on three years ago to serve as the associate director of genomics for the Office of Clinical Pharmacology, which itself is housed within the Office of Translational Sciences.

Frueh sat down with GT's Meredith Salisbury to talk about the growing relevance of genomics, proteomics, and more in the clinical realm. What follows is an excerpted transcript of the discussion.

Genome Technology: Why did FDA find it important to bring in someone to oversee genomics?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.